Remove 2019 Remove Cannabis Remove Research and Development Remove Treatment
article thumbnail

Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers

Veriheal

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. How Were the New Guidelines for Cannabis in Chronic Pain Developed?

article thumbnail

Scientists in China Develop Non-hallucinogenic Compounds That Relieve Depression

Veriheal

The need for effective treatment is not only important for restoring one’s health but also for returning functioning and quality of life. Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A New Kind of Depression Treatment. Increasing Options for Depression Patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

article thumbnail

NFL to Award Research Grant to Investigate Cannabis Therapy

Veriheal

It is a sad day in America when private corporations like Amazon and the NFL are making bigger moves to support the public opinion of cannabis than the elected representatives in the US government. To put that in perspective financially, the cannabis industry is predicted to produce $24 billion in sales this year. That says a lot.

Therapy 104
article thumbnail

Press Release: Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs

Cannabis Law Report

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.